- Home
- UNCY vs DIT Comparison
UNCY vs DIT Comparison
Compare UNCY & DIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- DIT
- Stock Information
- Founded
- UNCY 2016
- DIT 1981
- Country
- UNCY United States
- DIT United States
- Employees
- UNCY N/A
- DIT N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- DIT Food Distributors
- Sector
- UNCY Health Care
- DIT Consumer Discretionary
- Exchange
- UNCY Nasdaq
- DIT Nasdaq
- Market Cap
- UNCY 91.0M
- DIT 78.7M
- IPO Year
- UNCY 2021
- DIT 1995
- Fundamental
- Price
- UNCY $6.34
- DIT $106.90
- Analyst Decision
- UNCY Strong Buy
- DIT
- Analyst Count
- UNCY 4
- DIT 0
- Target Price
- UNCY $6.38
- DIT N/A
- AVG Volume (30 Days)
- UNCY 867.0K
- DIT 308.0
- Earning Date
- UNCY 08-13-2025
- DIT 07-17-2025
- Dividend Yield
- UNCY N/A
- DIT 0.71%
- EPS Growth
- UNCY N/A
- DIT N/A
- EPS
- UNCY N/A
- DIT 2.44
- Revenue
- UNCY N/A
- DIT $2,221,421,072.00
- Revenue This Year
- UNCY N/A
- DIT N/A
- Revenue Next Year
- UNCY $1,458.53
- DIT N/A
- P/E Ratio
- UNCY N/A
- DIT $41.84
- Revenue Growth
- UNCY N/A
- DIT 7.47
- 52 Week Low
- UNCY $2.02
- DIT $94.92
- 52 Week High
- UNCY $11.00
- DIT $166.00
- Technical
- Relative Strength Index (RSI)
- UNCY 48.29
- DIT 48.13
- Support Level
- UNCY $4.70
- DIT $94.92
- Resistance Level
- UNCY $7.58
- DIT $107.00
- Average True Range (ATR)
- UNCY 1.20
- DIT 4.16
- MACD
- UNCY -0.07
- DIT 0.25
- Stochastic Oscillator
- UNCY 26.03
- DIT 72.30
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About DIT AMCON Distributing Company
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores, and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.